NR 1,000 mg appears in several human studies and on the Tru Niagen Pro label. That makes the amount research-relevant, but it does not establish that a one-gram serving is necessary or best for every adult.
The evidence varies by population and endpoint. A stronger blood-NAD response, a tolerability observation, and an improvement in a health outcome are separate findings that should not be collapsed into one claim.
One-gram NR research supports specific biomarker observations. A higher amount and a larger NAD rise do not establish a better personal health outcome.
Read the two-capsule serving correctly
Tru Niagen Pro’s panel lists 1,000 mg nicotinamide riboside chloride per two vegetarian capsules. A 60-capsule bottle therefore supplies 30 labeled servings. The full serving, rather than the individual capsule, is the unit behind the 1,000 mg headline.
Check the specific product version when comparing it with NR 300 mg. A higher-strength product and a larger bottle of the standard product are different packaging choices.
What the eight-week dose study contributes
In the 2019 trial, the 1,000 mg arm produced a larger whole-blood NAD response than the lower study amounts. The result concerns the measured metabolite, with short-term safety observations in the enrolled population.
It does not establish that the larger response improved lifespan or everyday energy. A marketing phrase such as clinical strength should be evaluated against the endpoint in the paper, not treated as proof of superior benefit.
The direct NMN comparison adds context
A 2026 study compared one-gram NR and NMN interventions over 14 days and found comparable circulating-NAD increases. The NMN versus NR guide explains the short, open-label design and why the result is narrower than a general statement that the supplements work equally well.
The comparison is useful because it tests precursors directly. It still does not identify the best long-term choice for an individual.
A high amount is not a reason to stack products
NR may already be present in a multi-ingredient NAD formula. Adding another product changes the total exposure and may duplicate other ingredients as well. Read every Supplement Facts panel before discussing use with a clinician or pharmacist.
Do not convert findings from specialized disease trials into an unsupervised routine. Different eligibility criteria, monitoring, and goals can make those studies poor matches for general retail use.
The decision is bigger than a laboratory number
Compare the intended goal, evidence, product composition, cost, and practical routine. If a company promises a specific benefit, ask whether the study measured that benefit at this amount and with a comparable formula.
For the meaning of a single 500 mg capsule, read NR 500 mg. For a direct-NAD product using the same one-gram headline, use NAD+ 1,000 mg so that equal mass does not obscure a different molecule.
Sources & reading notes
Editorial source review updated September 19, 2026. Provider pages describe their own offers; inclusion does not verify a product or its results.
- Tru Niagen Pro: 1,000 mg product and label Manufacturer panel: 1,000 mg nicotinamide riboside chloride per two-capsule serving. Product description is not independent efficacy verification.
- Conze et al. (2019): NR dose-ranging trial Eight-week trial of 100, 300, and 1,000 mg NR. The 100 mg blood-NAD result differed from baseline but not placebo; biomarker findings are not longevity outcomes.
- 2026 human comparison of NR, NMN, and nicotinamide Randomized open-label 14-day study; 65 participants in the analysis. Comparable NR and NMN circulating-NAD responses do not establish long-term clinical equivalence.
- FDA: mixing medications and dietary supplements General interaction and surgery guidance; specific risks must be matched to the actual ingredient and medication.
- FDA: questions and answers on dietary supplements Regulatory categories and limits of premarket review.
Educational information, not individualized medical advice. We do not claim medical review or firsthand treatment experience. Read our review standards and commercial disclosure.